Medincell Sa Stock Current Ratio
MEDCL Stock | EUR 16.30 1.28 8.52% |
Medincell SA fundamentals help investors to digest information that contributes to Medincell's financial success or failures. It also enables traders to predict the movement of Medincell Stock. The fundamental analysis module provides a way to measure Medincell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medincell stock.
Medincell |
Medincell SA Company Current Ratio Analysis
Medincell's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Medincell Current Ratio | 4.14 X |
Most of Medincell's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medincell SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition |
In accordance with the recently published financial statements, Medincell SA has a Current Ratio of 4.14 times. This is 42.27% higher than that of the Healthcare sector and 40.86% lower than that of the Biotechnology industry. The current ratio for all France stocks is 91.67% lower than that of the firm.
Medincell Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medincell's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medincell could also be used in its relative valuation, which is a method of valuing Medincell by comparing valuation metrics of similar companies.Medincell is currently under evaluation in current ratio category among its peers.
Medincell Fundamentals
Return On Asset | -0.4 | |||
Operating Margin | (3.25) % | |||
Current Valuation | 180.29 M | |||
Shares Outstanding | 25.22 M | |||
Shares Owned By Insiders | 47.40 % | |||
Shares Owned By Institutions | 18.95 % | |||
Price To Book | 27.59 X | |||
Price To Sales | 20.97 X | |||
Revenue | 4.09 M | |||
Gross Profit | 4.09 M | |||
EBITDA | (21.45 M) | |||
Net Income | (24.81 M) | |||
Cash And Equivalents | 5 M | |||
Cash Per Share | 1.24 X | |||
Total Debt | 16.25 M | |||
Debt To Equity | 4.61 % | |||
Current Ratio | 4.14 X | |||
Book Value Per Share | (1.04) X | |||
Cash Flow From Operations | (21.36 M) | |||
Earnings Per Share | (1.12) X | |||
Target Price | 14.0 | |||
Number Of Employees | 151 | |||
Beta | 1.02 | |||
Market Capitalization | 215.89 M | |||
Total Asset | 44.3 M | |||
Z Score | 7.8 | |||
Net Asset | 44.3 M |
About Medincell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medincell SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medincell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medincell SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medincell Stock Analysis
When running Medincell's price analysis, check to measure Medincell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medincell is operating at the current time. Most of Medincell's value examination focuses on studying past and present price action to predict the probability of Medincell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medincell's price. Additionally, you may evaluate how the addition of Medincell to your portfolios can decrease your overall portfolio volatility.